Coccidioidomycosis in adolescents with lupus nephritis

Pediatric Nephrology

Volumn 16, Issue 1, 2001, Pages 77-81

  Yorgin, P D ^a   Rewari, M ^a   Al Uzri, A Y ^a   Theodorou, A A ^a   Scott, K M ^a   Barton, L L ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Adolescent; Amphotericin; Coccidioidomycosis; Fluconazole; Liposomal amphotericin; Systemic lupus erythematosus

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CEFTAZIDIME; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ERYTHROMYCIN; FLUCONAZOLE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG DISEASE; LUNG LAVAGE; LUPUS ERYTHEMATOSUS NEPHRITIS; NEEDLE BIOPSY; PRIORITY JOURNAL; RELAPSE; SEROLOGY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ABSCESS; ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; AMPHOTERICIN B; CHILD; COCCIDIOIDOMYCOSIS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; FLUCONAZOLE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; LIPOSOMES; LUNG DISEASES; LUPUS NEPHRITIS; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035143102     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670000468     Document Type: Article

References (35)

1. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs
2. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus
3. The effect of cyclophosphamide on B and T lymphocytes in patients with connective, tissue diseases
4. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus
5. Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital
6. Coccidioidomycosis in potentially compromised hosts: The effect of immunosuppressive therapy in dissemination
7. Lupus nephritis complicated by fatal disseminated coccidioidomycosis
8. In vivo and in vitro cell-mediated responses in coccidioidomycosis. I. Immunologic responses of persons with primary, asymptomatic infections
9. Coccidioidomycosis: A regional disease of national importance. Rethinking approaches for control
10. Systemic lupus erythematosus associated with fatal pulmonary coccidioidomycosis
11. Systemic lupus erythematosus complicated by coccidioidomycosis
12. Deep fungal infection in systemic lupus erythematosus - Three cases reported, literature reviewed
13. Reactivation of coccidioidomycosis in a fit American visitor
14. Acute pulmonary coccidioidomycosis mimicking bacterial pneumonia and septic shock: A report of two cases
15. Coccidioidomycosis
16. Fungal pneumonias; pulmonary coccidioidal syndromes, part I. Primary and progressive primary coccidioidal pneumonias - Diagnostic, therapeutic, and prognostic considerations
17. Coccidioidomycosis: Clinical update
18. Fungal pneumonias: Pulmonary coccidioidal syndromes, part 2. Miliary, nodular, and cavitary pulmonary coccidioidomycosis; chemotherapeutic and surgical considerations
19. Pattern of 39,500 serologic tests in coccidioidomycosis
20. Serology of coccidioidomycosis
21. Coccidioidomycosis in patients infected with human immunodeficiency virus: Review of 91 cases at a single institution
22. Detecting serum antibodies to a purified recombinant proline-rich antigen of Coccidioides immitis in patients with coccidioidomycosis
23. Practice guidelines for the treatment of coccidiodomycosis
24. Prediction of relapse after treatment of coccidioidomycosis
25. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis
26. Fluconazole therapy for coccidioidal meningitis
27. Coccidioidomycosis and pregnancy
28. Reactivation of coccidioidomycosis in pregnancy
29. Reactivation of coccidioides infection
30. Fungal infections in AIDS. Histoplasmosis and coccidioidomycosis
31. Coccidioides immitis in patients with human immunodeficiency virus infections
32. Coccidioidomycosis during human immunodeficiency virus infection: Results of a prospective study in a coccidioidal endemic area
33. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: Incidence, risk factors, and prevention